Importance of the time of initiation of mineralocorticoid receptor antagonists on risk of mortality in patients with heart failure
Introduction: Several studies have definitively shown the benefit of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure (HF). However, very few prior studies examined the relationship between the timing of initiation of MRAs and prognosis. In addition, on this topic, there...
Main Authors: | Rosario Rossi, Nicola Crupi, Francesca Coppi, Daniel Monopoli, Fabio Sgura |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publications
2015-03-01
|
Series: | Journal of the Renin-Angiotensin-Aldosterone System |
Online Access: | https://doi.org/10.1177/1470320313482603 |
Similar Items
-
Heart failure: the role for mineralocorticoid receptor antagonists
by: Bertram Pitt
Published: (2014-05-01) -
Clinical application of mineralocorticoid receptor antagonists in chronic heart failure
by: MG Bubnova
Published: (2014-12-01) -
Hyperkalaemia as a cause of undertreatment with mineralocorticoid receptor antagonists in heart failure
by: Josefin Henrysson, et al.
Published: (2023-02-01) -
Effects of Mineralocorticoid Receptor Antagonists in Early-Stage Heart Failure With Preserved Ejection Fraction
by: Kazuki Kagami, MD, et al.
Published: (2023-05-01) -
In the wake of the latest clinical guidelines - mineralocorticoid receptor antagonists in the treatment of chronic heart failure
by: I. V. Zhirov, et al.
Published: (2015-12-01)